ALK-3

General Information


DCTPep ID  DCTPep06067

Peptide Name   ALK-3

Sequence  CLKKLLKLLKKLLKLCLEELLHHLEELLHH

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide Cancer targeted peptides Membrane-targeted Targeted peptide conjugates



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma 70% Survival=20μM MTT assay 24h Patent

Hemolytic Activity  Mouse red blood cells:Hemolysis rate=5%=50μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys1<--->Cys16

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C170H294N44O39S2

Absent amino acids  ADFGIMNPQRSTVWY

Theoretical pI  8.76

Acidic residues  4

Basic residues  10

Polar residues  2

Molecular weight (Average)  3642.6

Molecular weight (Monoisotopic)  3640.18

Common amino acids  L

Net charge  6

Instability index (II)  21.6

Aliphatic index  182.00

Grand average of hydropathicity (GRAVY)  0.267

Half Life 
  1.2 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 125
  Abs 0.1% (=1 g/l) 0.034, assuming all pairs of Cys residues form cystines
  Ext. coefficient 0
  Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN110862458A

Patent Title  Combined peptide with acid-activated anti-tumor activity and clinical application of combined peptide

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.